MiCardia's Series B Round

MiCardia raised a round of funding on September 13, 2006.

MiCardia is dedicated to designing, developing and commercializing methods for treating heart disease. The company is developing enCor, a dynamically activated annuloplasty device that corrects residu…

Articles about MiCardia's Series B Round: